Who backs Enterome?
18 investors| Investor | Type |
|---|---|
| Omnes Capital | PE / buyout |
| Bristol-Myers Squibb | — |
| Primo Capital (Milano) | Venture capital |
| Takeda Ventures | Venture capital |
| Nestlé Health Science | Other |
| Danone | — |
| Genopole | — |
| INRAE (France) | — |
| Institute for Follicular Lymphoma Innovation | — |
| Leukemia & Lymphoma Society | — |
| + 8 more investors · a free account shows the complete list | |
The directory is free. Check sizes and activity — the working columns — are Pro.Unlock prospecting columns
Free account
See the evidence behind this price
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Enterome
- ·The full record, as it builds
Create free account
No card required
For fundraisers
Work this list, don’t just read it
These 18 firms already write checks for companies like Enterome. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.